神经炎症
炎症
重性抑郁障碍
抗抑郁药
病理生理学
免疫系统
全身炎症
神经科学
机制(生物学)
医学
病态行为
心理神经免疫学
心理学
免疫学
生物信息学
生物
内科学
扁桃形结构
海马体
哲学
认识论
作者
Gislaine Z. Réus,Luana M. Manosso,João Quevedo,André F. Carvalho
标识
DOI:10.1016/j.neubiorev.2023.105425
摘要
Notwithstanding advances in understanding the pathophysiology of major depressive disorder (MDD), no single mechanism can explain all facets of this disorder. An expanding body of evidence indicates a putative role for the inflammatory response. Several meta-analyses showed an increase in systemic peripheral inflammatory markers in individuals with MDD. Numerous conditions and circumstances in the modern world may promote chronic systemic inflammation through mechanisms, including alterations in the gut microbiota. Peripheral cytokines may reach the brain and contribute to neuroinflammation through cellular, humoral, and neural pathways. On the other hand, antidepressant drugs may decrease peripheral levels of inflammatory markers. Anti-inflammatory drugs and nutritional strategies that reduce inflammation also could improve depressive symptoms. The present study provides a critical review of recent advances in the role of inflammation in the pathophysiology of MDD. Furthermore, this review discusses the role of glial cells and the main drivers of changes associated with neuroinflammation. Finally, we highlight possible novel neurotherapeutic targets for MDD that could exert antidepressant effects by modulating inflammation.
科研通智能强力驱动
Strongly Powered by AbleSci AI